SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-22-006292
Filing Date
2022-03-08
Accepted
2022-03-08 16:02:08
Documents
6
Effectiveness Date
2022-03-08

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 79048
2 ex5-1.htm EX-5.1 24179
3 ex23-1.htm EX-23.1 3485
4 ex107-1.htm EX-FILING FEES 22634
5 ex5-1_01.jpg GRAPHIC 7504
6 ex5-1_02.jpg GRAPHIC 1748
  Complete submission text file 0001493152-22-006292.txt   143615
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263366 | Film No.: 22721662
SIC: 7389 Services-Business Services, NEC